Page last updated: 2024-09-04

febuxostat and Glomerulonephritis, IGA

febuxostat has been researched along with Glomerulonephritis, IGA in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, T; Fujishiro, M; Inoue, MK; Inoue, Y; Kushiyama, A; Masaki, T; Matsunaga, Y; Morii, K; Nakatsu, Y; Ono, H; Sakoda, H; Sasaki, K; Suzuki, Y; Ueda, K; Yamamotoya, T	1

Other Studies

1 other study(ies) available for febuxostat and Glomerulonephritis, IGA

Article	Year
The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model. International journal of molecular sciences, 2018, Dec-10, Volume: 19, Issue:12 Topics: Animals; Anti-Inflammatory Agents; Chemokines; Disease Progression; Endoplasmic Reticulum Stress; Febuxostat; Female; Fibrosis; Gene Expression Regulation; Glomerulonephritis, IGA; Inflammation Mediators; Kidney; Mice, Inbred BALB C; Xanthine Oxidase	2018

Article

Year

The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model.

International journal of molecular sciences, 2018, Dec-10, Volume: 19, Issue:12

Topics: Animals; Anti-Inflammatory Agents; Chemokines; Disease Progression; Endoplasmic Reticulum Stress; Febuxostat; Female; Fibrosis; Gene Expression Regulation; Glomerulonephritis, IGA; Inflammation Mediators; Kidney; Mice, Inbred BALB C; Xanthine Oxidase

2018